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A specific double-stranded DNA sensing system is of great interest for diagnostic
and other biomedical applications. Zinc finger domains, which recognize double-stranded
DNA, can be engineered to form custom DNA-binding proteins for recognition of specific
DNA sequences. As a proof of concept, a sequence-enabled reassembly of TEM-1 βlactamase system (SEER-LAC) was previously demonstrated to develop zinc finger
protein (ZFP) arrays for the detection of a double-stranded bacterial DNA sequence. Here,
we implemented the SEER-LAC system to demonstrate the direct detection of pathogenspecific DNA sequences present in E. coli O157:H7 on the lab-on-a chip. ZFPs customdesigned to detect shiga toxin in E. coli O157:H7 were immobilized on the cyclic olefin
copolymer (COC) chip, which can function as a non-PCR based molecular diagnostic.
Pathogen-specific double-stranded DNA was directly detected by engineered ZFPs
immobilized on the COC chip, providing a detection limit of 10 fmole of target DNA in
colorimetric assay. Therefore, in this study, we demonstrated a great potential of ZFP
arrays on the COC chip for further development of a simple and novel lab-on-a chip
technology for detection of pathogens.
Antibiotic resistance is a serious, and rapidly growing global threat. Here, we
designed a novel screening method to detect antibiotic resistance genes (ARGs) in bacteria
using a graphene oxide-based biosensor utilizing engineered ZFPs. Two-dimensional
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graphene oxide (GO) sheet possesses unique electronic, thermal, and mechanical
properties. The quenching ability of GO can create novel methods for detection of
biomolecules. Our approach utilizes quenching of fluorescence signal by GO in the absence
of target ARGs, but restoring the signal in the presence of target ARGs. Quantum dot (QD)labeled ZFP can bind to GO via stacking interactions of aromatic and hydrophobic residues
in conjunction with hydrogen bonding interaction between hydroxyl or carboxyl groups of
GO and hydroxyl or amine groups of the protein. Due to fluorescence resonance energy
transfer (FRET) between QD and GO when they are in close proximity, fluorescence signal
of QD-labeled ZFP is expected to be quenched. In the presence of target DNA, the bound
DNA-protein complex is released from GO, restoring the fluorescence signal.
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CHAPTER I – INTRODUCTION
1. DNA Detection
DNA detection technologies play an important role in diagnostic applications in the
areas of public health and biomedicine.1 Although numerous methods for DNA detection
have been developed, a simple, sensitive, and rapid technology for the detection of
pathogen-specific double-stranded (ds) DNA sequences still remains a challenge in
pathogen detection and clinical diagnostics.
1.1 Recognition Methods
Most of the current methods are based on DNA denaturation and subsequent
hybridization with its complementary probes, such as polymerase chain reaction (PCR),
DNA microarray, and fluorescence in situ hybridization (FISH). PCR has provided a
sensitive and faster method for pathogen detection than a traditional culture-based
method.2-4 On the other hand, nucleic acid amplification by PCR also requires multiple
primers and precise thermal cycling conditions to be discriminated from non-specific
amplification. DNA microarrays allow one to identify multiple pathogens simultaneously,
but they require DNA labeling and hybridization with their complementary probes, which
can increase the inaccuracy due to the cross-reaction of several probes with incorrect
targets.5 FISH has been studied in biomedical/clinical research, especially in diagnostics
for visualizing and detecting specific DNA/RNA sequences.6 However, FISH can be timeconsuming with limited sensitivity and its standardized protocol is not widely available.
Thus, direct detection of specific dsDNA through DNA-binding proteins enables us to
avoid the need for additional laborious steps involved in DNA denaturation and subsequent
hybridization. This is the novel aspect of our study which would enable us to develop
1

simple and rapid technology for DNA detection.
1.2 Zinc Finger Proteins
A Cys2-His2 zinc finger (ZF) domain, which contains 30 amino acids, is one of the
most common DNA-binding domains that can be found in various eukaryotic genomes.7-8
A ZF domain folds into a ββα structure that is stabilized by zinc coordination and
hydrophobic residues (Figure 1 (A)).9-10 Each domain can recognize three to four DNA
nucleotides using residues in position -1, 3, and 6 (Figure 1 (B)). Multiple ZF domains can
be linked together to form multi-finger proteins to recognize the extended DNA sequence.9,
11

Construction of multi-finger proteins enables us to improve the binding affinity and

specificity.9, 11 To further modify the specificity of zinc finger proteins (ZFPs), a modular
assembly approach has been used to assemble ZF domains targeting their respective 3 bp
subsites to recognize specific sequences of interest.11-14 Theoretically, a ZFP with six
fingers can recognize 18 bp of a specific DNA sequence, sufficient to recognize a unique
site within all known genomes.11-12, 15 Therefore, customized ZFPs can be created to detect
virtually any DNA sequence.8, 16
(A)

(B)

Figure 1. (A) A ZF domain ββα structure coordinated by zinc ion17 and (B) DNA contacting
residues.11
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2. Food-borne Pathogen and Antibiotic Resistant Bacteria
Recently, an increase in food-borne illness caused by food-borne pathogens has
become a serious threat worldwide, affecting public health.18 Shiga toxin-producing E. coli
O157:H7 is one of the most widespread and harmful among the food-borne pathogens.1920

E. coli O157:H7 outbreaks commonly occur in the US. Most recently, a multistate

outbreak of E. coli O157:H7 infections linked to romaine lettuce has occurred from April
to June 2018. According to the Centers for Disease Control and Prevention (CDC), a total
of 210 people from 36 states have been infected, resulting in five deaths. 96 people were
hospitalized due to this outbreak, 27 of which developed kidney failure – hemolytic uremic
syndrome. Developing a simple, rapid, and sensitive detection method for E. coli O157:H7
is of great important to prevent devastating outbreaks.
Antibiotics are widely used for prevention of bacterial infectious diseases in human
and veterinary medicine with 70% of antibiotics derived from actinomycetes bacteria.21-22
Antibiotic resistance (AR) jeopardizes the effectiveness of preventing and treating
infections. Antibiotic resistant bacteria (ARB) with ARG accumulation is considered a
critical global environmental problem with serious health, economic and political
consequences.22-23 ARB infections can happen anywhere and can be easily spread across
the globe. The majority of the antibiotics used on human/animals are partially metabolized
and are then discharged into hospital/municipal sewage waste system, which end up in
environmental water parts.22-23 Antibiotics are not only used extensively in
medicine/veterinary, but also in agriculture, which significantly increases the spreading of
ARG.24 Fertilizer or water containing feces from animals/livestock with ARB, which is
used on food crops, or meat from those animals will infect consumers with ARB.24

3

Additionally, ARB can transfer their AR to other bacteria via horizontal gene transfer of
ARG, causing even more problems.25

Figure 2. Example of how antibiotic resistance can spread (Centers for Disease Control
and Prevention – https://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf).
According to the Centers for Disease Control and Prevention’s (CDC) 2013 threats
report on antibiotic resistance in the United States, approximately 2 million people are
infected with ARB which results in 23,000 and many more deaths every year from ARB
and ARG related infections. There is currently no known method to stop or eliminate AR.
Simply using antibiotics will cause resistance, and because AR is a natural process in which
4

bacteria evolve, it can only be slow down. In order to prevent ARB from infecting and
spreading, new antibiotics and new diagnostic tests for ARG must be developed. Various
studies around the world have isolated and detect various ARG from different ARB strains
on the molecular level.26-30 However, a simple and rapid detection of ARG will be crucial
for early prevention and effective treatment of any infectious diseases.
3. Methods of Detection
DNA diagnostics require a detection method with a signal transducer.31 Recently,
several non-PCR-based detection methodologies for DNA and other analytes such as
proteins and viruses have been developed.1, 16, 32-34
3.1 SEquence Enabled Reassembly of β-lactamase (SEER-LAC)
Previously, a colorimetric detection method for visualizing specific DNA detection,
called the SEquence-Enabled Reassembly of β-lactamase (SEER-LAC) system, has been
developed.8,

16

This method utilizes enzymatic activities of TEM-1 β-lactamase which

hydrolyze the -lactam ring of nitrocefin substrate, creating a visible color change from
yellow to red.8 In this system, β-lactamase was dissected into two inactive fragments (LacA
and LacB), each linked to a ZFP.8 Upon specific binding of ZFPs to their target DNA
sequence, bringing the two inactive fragments in close proximity, LacA and LacB would
reassemble to become a full-length β-lactamase, restoring its enzymatic activities.8 Further
applications of the SEER-LAC system have led to the development of a ZFP array on a
poly(ethylene glycerol) (PEG) hydrogel-coated glass slide to detect bacterial dsDNA
sequences.16

5

3.2 Fluorescence Resonance Energy Transfer-based Detection
Fluorescence resonance energy transfer (FRET) is a physical phenomenon that
relies on the distance-dependent transfer of energy from a donor molecule to an acceptor
molecule.35 The donor molecule is a chromophore that initially absorbs the energy, and the
acceptor is the chromophore in which the energy is transferred to.36

Figure 3. Principle of FRET.37
3.2.1 FRET-based Sensors with Graphene Oxide
Graphene oxide (GO) is a two-dimensional nanosheet produced by the oxidation
and exfoliation of graphite.38 GO has a largely hydrophobic basal plane with epoxy and
hydroxyl groups, in conjunction with hydrophilic ionizable edges with carboxyl groups.3940

Aromatic domains and oxygen-rich functional groups allow GO to interact with DNA or

proteins through covalent, non-covalent, or electrostatic interactions.38,

41

Several

biosensors have been developed by taking advantage of the strong adsorption of dyelabeled DNA or proteins on GO surface with the subsequent fluorescence quenching effect
by GO via FRET.33-34, 42-45

6

Figure 4. Structure of Graphene Oxide.46
Dong’s group in 2010 has developed a DNA sensing system utilizing quantum dot
(QD) labeled molecular beacons (MBs) on GO surface.42 Molecular beacon is a singlestranded oligonucleotide hybridization probe with a stem-and-loop structure.47 The loop
contains a complementary sequence to the target DNA and the stem is formed by annealing
the self-complimentary ends. The QD-MB is adsorbed on GO surface due to the -
stacking interactions between aromatic domains of MB and GO, bringing the QD closer to
GO. Because of the close proximity, FRET occurs and QD’s fluorescence signal is
quenched. When target DNA is hybridized with QD-MB, the stem is disrupted due to
binding affinity changes. The distance between QD and GO is therefore increased,
hindering FRET and restoring the fluorescence signal of QD. Dong’s study has also
suggested possible applications for the detection of protein and other biomolecules using
aptamer/antibody-based biosensors.
Chen’s group in 2012 has utilized an approach of using an antibody-based sensor
with GO to effectively detect human Enterovirus 71 (EV71) and Coxsackievirus B3
(CVB3) simultaneously.33 Two different colors QD-labeled antibodies specifically to
EV71 and CVB3 are simultaneously adsorbed on GO surface via hydrogen bonding
7

interactions between the carboxyl or hydroxyl groups of GO and the carboxyl or amino
groups of antibodies in conjunction with - stacking interactions between aromatic
domains of GO and antibodies. Due to the FRET, fluorescence signals of QDs are
quenched. In the presence of one or both of the target viruses, the fluorescence intensities
of one or both QDs are restored due to the releasing of antibody-antigen complexes. This
method creates a simple and flexible multiplex detection of viruses with high sensitivity
and specificity.
Huang’s group in 2017 proposed a GO-based protein sensing system as an effective
alternative method to ELISA.34 Antibodies are covalently bound to GO surface by forming
a peptide bond chemically between carboxyl group of GO’s edge and amino group of the
antibody. The remaining GO surface is then blocked to ensure that the antigens will only
interact with the antibodies and not GO. Unlabeled antigens in various concentrations are
initially added to the antibody-modified GO solutions, occupying the various amount of
available antibodies. When labeled antigens are added to a fixed concentration of antigens
(labeled and unlabeled), they occupy the remaining antibodies. Because the amount of
conjugated antibodies is limited, some unbound labeled antigens will remain in the
solution. Since the labeled antigens are quenched by GO, one can measure the fluorescence
intensity of unbound labeled antigens in the solution and effectively quantify the amount
of antibody.
3.3 Application of Quantum Dots in Detection of Biomolecules
QDs are small semiconductor nanoparticles with the unique optical, physical, and
electrical properties.48 Compared to a conventional organic dye, QDs have several
advantages such as narrow, symmetric, and tunable emission wavelengths. Because the
8

dots are made of the same material, we can excite all of them at a single wavelength, enable
multiplexing.49 Recent studies on QDs for bio-compatibility and bio-conjugation have
developed QDs-labeled biosensors targeting various analytes.33, 42, 49-50 Previously, aminomodified DNA and proteins have been labeled with QDs using 1-ethyl-3-(3dimethylaminoprophyl) carbodiimide hydrochloride (EDC).51-56 EDC is a zero-length
crosslinking agent that activate carboxyl groups to conjugate with primary amines. EDC
reacts with a carboxyl group and forms an amine-reactive O-acylisourea intermediate that
quickly reacts with an amino group to form an amide bond and release of an isourea byproduct. However, the intermediate is unstable in aqueous solutions. Failure to react with
an amine will result in hydrolysis of the intermediate and subsequent regeneration of the
carboxyl groups, which will decrease the labeling efficiency. In the presence of Nhydroxysuccinimide (NHS), the unstable intermediate can be converted to a more stable
amine-reactive NHS ester. Thus, combining NHS with EDC would increase reaction
efficiency.

Figure 5. EDC crosslinking reaction scheme (Thermo Fisher Scientific).57
9

4. Surface for the Lab-on-a-chip Application
Several polymers including COC are considered for a substrate material for the labon-a-chip application.58 An ideal point-of-care diagnostic system should consist of
disposable cheap cartridges which can be manufactured in large quantities at a low cost. 32
The thermoplastic polymer COC has a definite advantage over PEG-coated glass slides in
this regard. Using a single aluminum mold, hundreds of replicable COC chips can be made,
which makes this polymer ideal for lab-on- a-chip-based diagnostic applications.32
Moreover, different types of microchannel surfaces can be more easily fabricated on the
COC using the injection molding technique. This can provide a larger surface-to-volume
ratio and improved sensitivity for future applications. Also, the COC exhibits optical
transparency over a wide range including the UV spectrum which makes it ideal for
biochemical analyses and bio-optical applications.59-60 In addition to that, resistance to
polar solvents, high biological compatibility, low background noise, and easy control of
non-specific adsorption prompt the use of COC as a better substrate material in this
study.59-61 The COC displays a very high flow rate during injection molding as compared
to other polymer materials like polycarbonate (PC) or polymethyl methacrylate (PMMA)
and its low viscosity allows for lower injection pressure and better fills.62 Thus, the COC
can serve as an ideal platform for developing low-cost, disposable lab-on-chip devices for
pathogen detection.
5. Aims of Study
In this study, we will demonstrate two different methods of detecting doublestranded DNA utilizing engineered ZFPs.

10

5.1 Pathogenic DNA Detection with SEER-LAC System
As the first part of our study, we implemented the SEER-LAC system to
demonstrate the direct detection of pathogen-specific DNA sequences of stx2 gene present
in E. coli O157:H7 on a ZFP array on a transparent polymer surface.32 The cyclic olefin
copolymer (COC) chip was fabricated to function as a surface for ZFP immobilization.
Engineered ZFPs were deposited within a confined area of a silicone gasket on a COC chip,
which can function as a simple and inexpensive detection platform for specific pathogen
detection. Our approach provides rapid visual detection with high specificity and
sensitivity, suggesting that ZFP arrays on the COC chip could be further developed into a
novel and reliable molecular diagnostic device for multiplexed detection of pathogens.
5.2 Graphene Oxide-based DNA Detection Method
GO-based method for detecting double-stranded (ds) DNA has been studied
previously.45 Because of its preferential binding to single-stranded DNA, GO was
introduced to remove primers that were used for amplification of csp gene in E. coli. The
amplified DNAs were then hybridized with dye-labeled single-stranded oligonucleotides.
Upon the addition of GO, the fluorescence signal of unbound labeled oligonucleotides was
quenched. Thus, in the presence of target DNA, the fluorescence signal would remain in
solution because of the hybridization. However, this method relies on PCR and is subjected
to the limitations of PCR aforementioned. In the second part of our study, we will
demonstrate a new GO-based sensing technology for double-stranded (ds) DNA detection
utilizing engineered ZFPs. In this approach, we will use the fluorescence of QDs as our
signal transducer. QD-labeled ZFP can be adsorbed on GO surface via aromatic stacking
interactions between the aromatic residues of ZFPs and the aromatic basal plane of GO, in
11

conjunction with hydrogen bonding between hydroxyl or carboxyl groups of GO and
hydroxyl or amine groups of ZFPs. Protein adsorption on GO surface will bring QD in
close proximity with GO, quenching QD’s fluorescence signal. In the presence of target
DNA, DNA-ZFP complexes will be released from the GO surface, restoring fluorescence
signal of QDs. This on-off effect of fluorescence signal will serve as a detection method
for our assay. Multiple ZFPs will be engineered to develop and validate the GO-based
sensor for antibiotic resistance gene (ARG) detection.

12

CHAPTER II – EXPERIMENTAL
1. Protein Engineering
Three pairs of ZFPs (stx2_233 and stx2_268; stx2_525 and stx2_560; stx2_1093
and stx2_1128) were used for the SEER-LAC system detection method, which were
designed to target the stx2 gene presence in Shiga-toxin producing pathogen E. coli
O157:H7. ZFP stx2_268 was used as a proof of concept for a GO-based detection method.
Six ZFPs were also engineered to detect a tetracycline resistance gene using the GO-based
detection method.
1.1 Construction ZFPs
ZFPs were constructed by the modular assembly method using the Barbas set of
pre-defined ZF modules.14 The DNA coding regions for each ZFP were commercially
synthesized by Bio Basic. ZFPs (stx2_268, tetM_75, tetM_110, tetM_ 641, tetM_676,
tetM_1297, and tetM_1332) were sub-cloned between the BamHI and HindIII sites of
pMAL-2cX full-length -Lactamase, replacing the full-length -Lactamase. The pMAL
vector was used for bacterial expression of the proteins as fusions with an N-terminal
maltose binding protein (MBP) as a purification tag.
1.1.1 Construction of the SEER-LAC System ZFPs
Each pair of ZFPs consists of ZFP(A) and ZFP(B). The ZFP(A)s (stx2_268,
stx2_560, and stx2_1093) were sub-cloned between the XmaI and HindIII sites of pMALc2X LacA-rrsA1175, replacing the C-terminal rrsA1175 ZFP. The ZFP(B)s (stx2_233,
stx2_525, and stx2_1128) were sub-cloned between the BamHI and AgeI sites of pMALc2X rrsA1192-LacB, replacing the N-terminal rrsA1192 ZFP.
13

Figure 6. Location of target regions of stx2 ZFP pairs in stx2 gene (1241 bp). Target sites
are highlighted for stx2_233/stx2_268 (yellow), stx2_525/stx2_560 (cyan), and
stx2_1093/stx2_1128 (light green).
1.2 Expression and Purification of ZFPs
Proteins were expressed in E. coli BL21 (Invitrogen) upon induction with 1 mM
isopropyl -D-1-thiogalactopyranoside (IPTG) at an OD600 of 0.6–0.8 for 3 h at 37°C. Cells
were pelleted and re-suspended in Zinc Buffer A (ZBA: 100 mM Tris base, 90 mM KCl,
1 mM MgCl2 and 100 mM ZnCl2 at pH 7.5) including 5 mM dithiothreitol (DTT) and 50
mg/mL RNase A. After sonication, proteins in cell lysates were applied to an amylose resin
column (Bio-rad) pre-equilibrated with ZBA + 5 mM DTT, washed with ZBA + 2 M NaCl
and ZBA + 1 mM Tris(2-carboxyethyl)phosphine (TCEP), and eluted in ZBA + 10 mM
Maltose + 1 mM TCEP. Concentration and purity were assessed by Coomassi-stained
polyacrylamide gel electrophoresis with sodium dodecyl sulfate (SDS–PAGE) and

14

Bradford assay using bovine serum albumen (BSA) standards. Purified protein was stored
on ice at 4°C until use.
2. Fabrication of the COC Chip
A cyclic olefin copolymer (COC) of grade 5013-S was obtained from TOPAS
Advanced Polymers (KY, USA). COC chips were fabricated using a polymer injection
molding machine (BOY 22A, Procan, CT, USA). The COC thermoplastic in the form of
pellets is heated in a barrel and this molten plastic in the barrel is forced into a small cavity
containing the features to be replicated. The cavity is cooled down and the solid plastic part
is ejected from the mold cavity. As per the processing datasheet of TOPAS 5013S-04, the
injection molding parameters were optimized and are as follows: nozzle temperature:
565°F, mold temperature: 480°F, speed of injection: 85 mm s-1, and back pressure: 2000
psi. The process cycle time was optimized to 35 seconds, thus ensuring a lower injection
molding cost and increasing the throughput of the process. The COC chip was fabricated
as an array spot lab-chip. Plain COC disks of 1 mm thickness and 76.2 mm diameter were
produced by injection molding using a blank polished aluminum disk as the mold. An array
spot aligned with an individual well in a 96-well plate was marked and covered with
chemical resistance tape. The spots were 7 mm in diameter with a pitch of 9 mm, the same
as in the 96-well plates (Figure 7 (A)). The rectangular array lab chips were incubated in
phosphate buffered saline (PBS) for 15–45 min and then dried. The tapes were removed
and the chips were ready for testing.
3. ZFP Array and Nitrocefin Assay with COC Chip
DNA target oligonucleotides were commercially synthesized by IDT and prepared
by heating to 95°C for 10 minutes, then slowly cooling to room temperature to form
15

hairpins containing a four-thymidine loop. A silicone gasket with a diameter of 6 mm and
a well depth of 1 mm (Grace Bio-Labs, Bend, OR) was placed onto the cyclic olefin
copolymer (COC) surface to confine the areas of ZFP immobilization before arraying the
ZFPs. 5 μL of a purified protein LacA-ZFP(A) at a concentration of 2.5 μM was pipetted
onto the COC surface and incubated for 40 minutes. 10 μL of hairpin target DNA solution
was added on the ZFP array and incubated for 20 minutes to allow DNA binding to the
ZFP. The slide was washed with ZBA + 50 mM KCl and ZBA + 0.05% Tween-20,
followed by air-drying. 10 μL of a purified protein ZFP(B)-LacB was added on the ZFP
array and incubated for 20 minutes to allow the ZFP to bind the DNA that was complexed
with the LacA-ZFP(A). The slide was washed with ZBA + 50 mM KCl and ZBA + 0.05%
Tween-20, followed by air-drying. After placing the slide onto a 96-well plate and aligning
the arrays with the wells, 20 μL of 1 mM nitrocefin (Calbiochem, San Diego, CA, USA)
was added to the ZFP array. Absorbance at 486 nm was monitored with a Spectramax 190
(Molecular Devices, Sunnyvale, CA, USA). All experiments were repeated in duplicate,
and the standard error was calculated from duplicate samples.
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Figure 7. (A) An image of the COC array spot chip and (B) A schematic diagram of a ZFP
array on the COC chip.
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4. Electrophoretic Mobility Shift Assay (EMSA)
Complementary pairs of 5’-biotin labeled forward and 5’-poly T reverse
oligonucleotides were annealed by heating to 95°C for 3 minutes, and cooling to 4°C by
1°C per 50 seconds to obtain double-stranded target DNAs. Binding reactions were
performed at room temperature in the dark for 1.5 hour in ZBA containing 150 mM KCl,
5 mM DTT, 10% glycerol, 0.1 mg/mL BSA, 0.05% NP-40, 5 pmol target DNA and purified
ZFPs with concentrations ranging from 0.6 to 500 nM. Gel electrophoresis was performed
in the cold room on a 10% native polyacrylamide gel in 0.5 X TBE buffer. After blotting
on a nylon membrane by transferring in the cold room, the DNA was cross-linked by a UV
cross-linker for 4 minutes. After that, EMSA was performed using the Light Shift
Chemiluminescent EMSA Kit (Pierce, Rockford, IL, USA) according to the
manufacturer’s protocol.

Chemiluminescent signal was read using AlphaImager HP

(ProteinSimple, San Jose, CA, USA)
5. Binding Site Selection Assay using Bind-n-Seq
Binding sites of engineered ZFPs were identified using Bind-n-Seq as described.63
Barcoded 95-mer double-stranded oligonucleotides containing Illumina primer binding
sites and a 21-nt random region were incubated with different protein concentrations (500
nM, 50 nM, and 5 nM final) and salt concentrations (100 mM, 50 mM, and 1 mM final) in
BnS buffer (0.12 μg/μL herring sperm DNA, 5 mM DTT, 1% BSA). Binding reactions
were carried out at room temperature for 2 hours. Bound complexes were enriched
followed by six washing steps with the corresponding salt buffers. Eluted DNA were
quantified and sufficiently amplified for sequencing. Sequencing reads were filtered and
sorted using custom Perl scripts found in the MERMADE package, an updated version of
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the Bind-n-Seq data analysis pipeline. MERMADE is freely available with user
documentation at http://korflab.ucdavis.edu/Datasets/BindNSeq
6. GO Preparation and Surface Characterization
GO dispersion (ACS Material, Pasadena, CA, USA) was vortexed to ensure
homogeneous solution before diluting using water. A serial dilution was performed for the
preparation of different GO concentrations. The stock GO dispersion of 5 mg/mL was
initially diluted to 1 mg/mL, and subsequently diluted down to 20 g/mL with 100 g/mL
decrease in concentration from 1 mg/mL to 100 g/mL, and 10 g/mL decrease in
concentration from 100 to 20 g/mL of GO. The single-layer ratio is >80% with the sizes
of GO sheets ranging from 0.5 to 2.0 m and thickness of 0.6 – 1.2 nm. The morphology
of GO was measured with transmission electron microscope (TEM) JEM-1400plus (JOEL,
Peabody, MA, USA). The UV-Vis absorption spectrum was measured by the Synergy H1
multi-plate reader (BioTek Instruments, Winooski, VT, USA).
7. Quantum Dots Labeling
Carboxyl PEG functionalized CdSe/ZNs quantum dots in water with an emission
peak of 520 nm (Creative Diagnostics, Shirley, NY, USA) were covalently conjugated with
ZFPs using EDC/NHS chemistry. QD:EDC molar ratio was initially optimized by labeling
using a set concentration of NHS and different concentrations of EDC. QD:EDC:NHS
molar ratio was then optimized using the determined optimal concentration of EDC and
different concentrations of NHS. The molar ratio of QD:EDC:NHS was determined to be
1:4000:8000, respectively (refer to the result section). For QD labeling, 10 L of 10 M
QDs were added to 70 L of HEPES buffer (20 mM HEPES, 90 mM KCl, 1 mM MgCl2
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and 100 mM ZnCl2 at pH 7.5). 10 L of 40 mM EDC (Thermo Scientific, Rockford, IL,
USA) and 10 L of 80 mM NHS (Thermo Scientific, Rockford, IL, USA) were added to
the solution and mixed end-to-end for 20 minutes. Subsequently, 100 L of 5 M ZFP was
added into the reaction and mixed end-to-end for 2 hours. Excess EDC/NHS and unlabeled
ZFPs were removed using 0.5 mL 100K MWCO ultrafiltration unit (Pierce, Rockford, IL,
USA) at 15,000 x g for 10 minutes. The concentration of unlabeled ZFPs in the flowthrough was measured by Bradford assay. Labeled proteins concentration was calculated
by subtracting the unlabeled ZFPs from the initial ZFPs concentration. Labeled proteins
were stored in ZBA at 4°C in the dark before use.
8. ZFP Assay with GO
In a black 96-well plate with a clear flat bottom (Corning, Kennebunk, ME, USA),
20 L GO dispersion, 20 L of QD-labeled ZFPs, and 20 L of target DNA with
appropriate concentrations were added to 140 L of ZBA in each well. The solutions were
mixed by pipetting and allowed to sit for 10 minutes. The fluorescence intensity and
emission spectrum were measured by Synergy H1 multi-plate reader (BioTek Instruments,
Winooski, VT, USA). Fluorescence intensity was measured with excitation wavelength
(ex) of 370 nm and emission wavelength ((em) of 515 nm. Fluorescence emission
spectrum was measured with ex of 370 nm and em from 400 nm to 650 nm with a 5 nm
slid width and a gain of 75. All optical measurements were performed at room temperature
under ambient conditions.
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Figure 8. Schematic diagram of a ZFP assay with GO.
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CHAPTER III – RESULTS AND DISCUSSION
1. Pathogenic DNA Detection with SEER-LAC System
Previously, we have demonstrated our initial proof-of concept on a simple capturedetection probe assay to detect the 16S ribosomal DNA sequence of a non-pathogenic
strain of E. coli.16 In this study, we implemented our system to further develop a molecular
diagnostic for detecting a food-borne pathogen E. coli O157:H7. In addition, a new
copolymer surface was used to immobilize ZFPs as a choice of a substrate material for the
lab-on-a chip.
1.1 ZFP Array on the COC Chip
Three pairs of ZFPs were engineered to recognize a pathogen-specific gene stx2
encoding for Shiga toxin present in E. coli O157:H7. Three pairs of six-finger ZFPs were
constructed targeting three different sites in stx2, which are stx2_233LacB/LacA stx2_268,
stx2_525 LacB/stx2_560 LacA, and LacA stx2_1093/stx2_1128 LacB (Table 1). LacA
was attached to the N-terminus of the capture probe ZFP(A)s and LacB to the C-terminus
of the detection probe ZFP(B)s. Since the stx2_1093/stx2_1128 pair binds to its target
DNA on the sense strand, LacA was linked to stx2_1093, and LacB was linked to
stx2_1128. The other two pairs, however, bind to their target DNA on the antisense strand.
Thus, LacA was linked to stx2_268 and stx2_560, while LacB was linked to stx2_233 and
stx2_525. This design would ensure that LacA and LacB fragments are juxtaposed upon a
pair of ZFPs binding to the continuous target sites of 36 bp.
Figure 7 (B) represents our system where a capture probe ZFP(A) linked to a LacA
fragment was immobilized on the COC chip, followed by dsDNA binding with the protein,
forming the protein–DNA complex. Subsequently, a washing step was performed to wash
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off unbound molecules, followed by the binding of a detection probe ZFP(B) attached to a
LacB fragment. When brought into close proximity upon ZFP binding to the target sites,
the two inactive fragments LacA and LacB would reassemble into a full-length βlactamase, which then hydrolyzes the β-lactam ring of the nitrocefin substrate, converting
its color from yellow to red. This system generated a visual signal that indicates ZFP
binding to their specific target DNA sequences.
Table 1. Sequences of zinc finger recognition modules and their corresponding 3 bp DNA
subsites, and the kD values of zinc finger proteins
ZFP

Position

Finger 6

Finger 5

Finger 4

Finger 3

Finger 2

Finger 1

Target site
Stx2_233
Target site
Stx2_268

233

CCT
TSGNLVR
GAA
RSDDLVR

GAT
QSGNLTE
GAT
DSGNLRV

AGA
TSGNLTE
GGT
QSGNLTE

CAT
QLAHLRA
CAA
TSGHLVR

CAA
TSGNLVR
AAC
TSGNLVR

GCC
TKNSLTE
GCG
QSSNLVR

Target site
Stx2_525
Target site
Stx2_560

525

AGA
QSGDLRR
GTG
HTGHLLE

ACT
TSGNLVR
ACA
QRANLRA

GCT
RNDALTE
GTG
SPADLTR

CTG
TSGELVR
ACA
RSDELVR

GAT
THLDLIR
AAA
SPADLTR

GCA
QLAHLRA
CGC
RSDELVR

Target site
Stx2_1093
Target site
Stx2_1128

1093

AAG
TTGNLTV
ACT
QRAHLER

TGG
RKDNLN
GGA
TSGELVR

CCG
QRAHLE
CCA
DPGALVR

GGA
RNDTLTE
GTC
TSHSLTE

AAG
RSDHLTT
GCT
QRAHLER

AAT
RKDNLKN
GGA
THLDLIR

268

560

1128

1.2 Sensitivity
ZFP arrays were prepared with each pair of ZFPs at various target DNA
concentrations ranging from 2.5 μM to 1 nM to determine the sensitivity of our system in
the presence of their own target DNAs (Figure 9). A linear DNA dose calibration curve
was generated from the data, showing a linear and quantitative assay. All the ZFP pairs
were able to detect their own target DNAs in the range of 5 nM to 2.5 μM. Among the three
pairs, the ZFP pair LacA stx2_268 and stx2_233 LacB was most sensitive because it was
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kD
(nM)
3.56
1.98

4.50
200

75
51.3

able to detect 1 nM of DNA which is equal to 280 pg or 10 fmol of oligonucleotide target
DNA (P < 0.05). The other two pairs of ZFPs were sensitive enough to detect 5 nM of
target DNA, but not 1 nM of target DNA, indicating a limit of detection >1 nM (P < 0.05).

Figure 9. The limit of detection of the three ZFP pairs. (A) The ZFP pair LacA stx2_268
and stx2_233 LacB, (B) the ZFP pair LacA stx2_560 and stx2_525 LacB, and (C) the ZFP
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pair LacA stx2_1093 and stx2_1128 LacB. Final data points obtained after incubation with
an asterisk (*) indicate significant differences (P < 0.05) (ns: not significant).
The limit of detection of this study is ≤10 fmol, which is equivalent to 280 pg of
DNA. Using a new surface platform resulted in a five-fold improvement in the sensitivity
compared to the previous study.16 For E. coli O157:H7, real-time PCR pro-vides the limit
of detection of 2 × 102 CFU ml−1 with an assay time of 24 hours.64 In the oligonucleotide
DNA microarray, the limit of detection for E. coli O157 is 0.1 pg for each genomic DNA.65
Although the detection methods of the leading DNA techniques are different from those of
our system, our method is currently not as sensitive as these methods because we are still
at the early stage of further developing our sensing system to improve the sensitivity. More
importantly, the novel aspect of our system is that it does not require DNA labeling or
DNA denaturation and subsequent hybridization under controlled conditions which the
leading DNA-based methods require. In addition, the leading DNA-based techniques must
be performed at an elevated temperature. However, our method does not require careful
control of the temperature by generating an isothermic enzymatic amplification of a visual
signal. A color change from yellow to red on the surface in this study does not require
sophisticated instrumentation, unlike PCR, which requires a thermal cycler. With regard to
reaction time, PCR could take up to a couple of hours whereas our system generates a
signal within 5 – 10 min. PCR requires trained personnel to prepare a reaction mixture
including a DNA Taq polymerase, primers, deoxyribonucleotide triphosphates (dNTPs),
and a reaction buffer. However, our method does not require these reagents such as
carefully designed primers and a temperature-sensitive DNA polymerase enzyme and
simply involves the addition of DNA and the detection ZFP on the surface.
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In principle, a solution-based assay would allow more flexible orientations of ZFPs
to fully interact with DNA compared to the immobilization of ZFPs on the 2D COC
surface. However, immobilizing ZFPs on the COC surface allows us to wash off unbound
molecules that could not be done in a solution-based assay. Also, ZFP immobilization can
be a superior platform for developing a point-of-care detection device with the ability to
simultaneously detect multiple pathogenic DNA sequences.16 In our future study, a
different immobilization method can be developed, which allows flexible orientations of
ZFPs to capture more of target DNA, thus improving the sensitivity. In addition, we would
also investigate a more sensitive detection method to generate an exponential signal rather
than a linear amplification of a signal.
1.3 Specificity of Engineered ZFP Recognition
ZFP arrays were examined to demonstrate the specificity of the ZFP pairs in the
presence of their own target DNA as well as non-target DNAs. Target sites 1, 2, and 3 are
the

target

DNA

sequences

for

stx2_268/stx2_233,

stx2_560/stx2_525,

and

stx2_1093/1128, respectively. An irrelevant DNA sequence being the target site for Zif268
and PBSII, which is not present in the E. coli genome, was also included. As shown in Fig.
10, when a ZFP pair was incubated with its own target DNA, the signal was distinctively
high compared to those of non-target and irrelevant DNAs. Thus, all of the ZFP pairs were
able to distinguish their own targets from non-targets and irrelevant sequences.
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(A)

(C)

(B)

Figure 10. The specificity of ZFP pairs (DNA concentration of 2.5 M). (A) The ZFP pair
LacA stx2_268 and stx2_233 LacB, (B) the ZFP pair LacA stx2_560 and stx2_525 LacB,
and (C) the ZFP pair LacA stx2_1093 and stx2_1128 LacB. The corresponding digital
image of the nitrocefin assay is represented on the top of each bar graph in (A).
With high specificity, our ZFP array was able to detect a specific double-stranded
pathogenic DNA sequence. However, it is unclear if this level of differentiation between
target DNA and non-cognate DNA would be sufficient for real-world diagnostics. Since
we are still at the early stage of developing and optimizing our system with ZFPs, further
development of a new surface for better/optimized ZFP immobilization can lead to
capturing more DNA and an improved detection method with exponential signals. Since
our assay generates a color change from yellow to red upon ZFP binding to its target DNA,
the color change should be able to tell us whether the target DNA is detected or not as
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shown in the digital image of the nitrocefin assay in Figure 10 (A). In a real-world
diagnostic that we envision in the future, the red color would indicate infection, the
presence of a specific pathogen, and the yellow color would imply no infection.
Table 2. Binding motifs identified by Bind-n-Seq for stx2_233 LacB, LacA stx2_268,
stx2_525 LacB, LacA stx2_560, LacA stx2_1093, and stx2_1128 LacB.

Motifs

Seed

Enrichment

Protein

Salt

AAGATAGACC

42.667

50 nM

100 mM

AGGAAGATGG

86.750

5 nM

100 mM

ATGGATGCA

115.500

50 nM

50 mM

ACAAAAA

0.157

50 nM

50 mM

CTTTCCCGCC

26.432

500 nM

100 mM

AGTTGGTCG

4.345

50 nM

1 mM

CCTGATAGACATCAAGCC
Stx2_233
LacB

GAAGATGGTCAAAACGCG
LacA
Stx2_268

AGAACTGCTCTGGATGCA
Stx2_525
LacB

GTGACAGTGACAAAACGC
LacA
Stx2_560

AAGTGGCCGGGAAAGAAT
LacA
Stx2_1093

ACTGGACCAGTCGCTGGA
Stx2_1128
LacB

Understanding interactions between DNA and proteins has been one of the major
issues to be addressed in biology and biophysics.66 Understanding DNA–protein
interactions provides us with a better understanding of the recognition of their DNA targets
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and gene regulation. The in vitro binding motifs of our engineered ZFPs were determined
by using Bind-n-Seq, a target site selection assay using a massively parallel sequencing
technology.63 Interestingly, the motifs for stx2_233 LacB, LacA stx2_268, and stx2_525
LacB are found to be toward the middle, 5′ end, and 3′ end of their target sequences,
respectively (Table 2). Since ZFPs have a sequence preference toward 5′-GNN-3′,12-13, 67
their binding motifs may have been affected by the positions of ZF domains targeting the
5′-GNN-3′ triplet. It could also indicate that these motifs are the highest binding affinity
regions of these proteins, and the regions that primarily determine the specificity. The
strong motifs were revealed by the ZFPs with high affinities. Likewise, the reasonable
binding motif was not obtained for LacA stx2_560 with low affinity. These data suggest
that the binding affinity obtained by EMSA may correlate with the identification of
reasonable binding motifs.
1.4 DNA Binding Affinity
The binding specificity of ZFPs and their binding affinity toward their target DNAs
are one of the key factors controlling the function of ZFP in vivo.67 There might be multiple
factors that affect the binding affinity of engineered ZFPs, demonstrating a wide range of
affinities and specificities to their target sequences.13-14, 16, 67-68 We examined the binding
affinities of our engineered ZFPs toward their respective target DNA sequences using
EMSA. The binding affinities of the ZFPs to their targets were determined to be in a range
from 1.98 nM to 200 nM (Table 1) which are in the range of the reported kD values for sixfinger ZFPs.1, 13, 16 The kD values of the capture probe ZFPs are 1.98, 200, and 75 nM for
LacA stx2_268, LacA stx2_560, and LacA stx2_1093, respectively, differing by up to a
100-fold. The highest affinity capture probe was paired with the detection probe stx2_233
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LacB whose affinity is similar to that of the capture probe. The sensitivity of the LacA
stx2_268/stx2_233 LacB pair differs five-fold compared to those of the other two pairs.
The combination of two very high affinity ZFPs resulted in the highest sensitivity among
the three ZFP pairs, without compromising the assay specificity. The higher affinity ZFP
pair may have retained its DNA for a longer period than the lower affinity pairs. The
difference in binding affinities may have contributed to the differences in the sensitivity of
a ZFP pair on the array.
(A)

(B)

(C)

(D)

(E)

(F)

Figure 11. Illustration of EMSA for (A) stx2_233 LacB, (B) stx2_268 LacA, (C) stx2_525
LacB, (D) stx2x_560 LacA, (E) stx2_1093 LacA, and (F) stx2_1128 LacB. The ZFP
concentrations (nM) are given at the top. Top bands indicate the ZFP and DNA complex
and the bottom bands show free DNA.
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2. DNA Detection with a GO-based Sensing System
As a proof of concept, ZFP stx2_268 was used in this study to demonstrate a new
GO-based sensing technology for dsDNA detection. Different ZFPs will be engineered to
develop and validate the GO-based sensor for antibiotic resistance gene (ARG) detection.
2.1 GO Characterization
TEM image of GO sheet showed that the GO sample was indeed a monolayer with
occasional folds, wrinkles, and rolled edges (Figure 12 (A)). The UV-Vis absorption graphs
with different GO concentrations showed that the absorbance of diluted GO dispersion was
proportional to the GO concentration (Figure 12 (B)). We also determined a range of GO
concentrations from 0 to 5 g/mL for the following experiments of sensitivity (Figure 12
(C)).
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(A)

(B)

(C)

Figure 12. (A) TEM image of monolayer GO sheet (B) GO absorbance at 300 nm with
concentrations from 0 to 100 g/mL (C) GO absorbance at 300 nm with concentrations
from 0 to 10 g/mL.
2.2 QD Labeling Optimization
The EDC/NHS molar ratio has been optimized for QD labeling. For EDC
optimization, different concentrations of EDC (300, 1000, 4000, and 8000 M) were used
with a fixed QD:ZFP:NHS molar ratio of 1:5:8000 for labeling. Fluorescence intensity of
QD-labeled ZFPs for each EDC concentration was measured after labeling (Figure 13(A)).
Based on the fluorescence intensity, the optimal QD:EDC molar ratio for labeling was
determined to be 1:4000. For NHS optimization, different concentrations of NHS (4000,
6000, 8000, and 10000 M) were used with a fixed QD:ZFP:EDC molar ratio of 1:5:4000
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for labeling. Based on the fluorescence intensity (Figure 13 (B)), the optimal
QD:EDC:NHS molar ratio for labeling was determined to be 1:4000:8000.
(B)
30000

3900

29500

3800

29000

3700

RFU

RFU

(A)

28500

3600

28000

3500

27500

3400
3300

27000
300:8000

1000:8000

4000:8000

4000:4000

8000:8000

4000:6000

4000:8000

4000:10000

EDC:NHS molar ratio (µM)

EDC:NHS molar ratio (µM)

Figure 13. (A) EDC optimization with different concentrations of EDC (300, 1000, 4000,
and 8000 M) and (B) NHS optimization with different concentrations of NHS
(4000,6000, 8000, and 10000 M).
2.3 GO Quenching Efficiency
Recent studies have shown that GO is a universal quencher for fluorescence
molecules such as fluorescence amino acids/peptides/proteins, organic dyes, and quantum
dots.33-34, 42, 69 The effect of GO concentration on QD-labeled protein was studied over the
range of 1 to 100 g/mL (Figure 14). A Stern-Volmer plot of F0/F against the concentration
of GO (Figure 14 (D)), where F0 and F were the fluorescence intensity at the maxima in
the absence and presence of GO, respectively, showed a linear quenching effect when GO
was added to the solution. The quenching efficiency of QD-labeled ZFPs by GO was
calculated using the following equation, where F0 and F were the fluorescence intensity at
the maxima in the absence and presence of GO, respectively:
% Quenching efficiency = 100 −

F
× 100
F0

At 10 µg/mL of GO, the fluorescence intensity of QD-labeled ZFPs rapidly
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decreased with a quenching efficiency of approximately 42%. With increasing
concentrations of GO, a linear trend in increasing quenching efficiency was observed. At
approximately 70 µg/mL of GO, the quenching efficiency almost reached a plateau. Thus,
70 µg/mL of GO was initially chosen as a set concentration of GO throughout the study
because excess GO would be unfavorable for desorption of ZFPs from GO surface via
protein-DNA interaction.
(A)

(C)

(D)

(B)

Figure 14. Changes in fluorescence spectra (A), fluorescence intensity (B), quenching
efficiency (C) of QD-labeled ZFPs by increasing concentrations of GO from 0 to 100
µg/mL (D) Stern-Volmer plot of QD-labeled ZFPs against increasing concentration of GO.
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However, when ZFP assay was performed to examine the sensitivity of our system,
only 2.5 µM of target DNA showed restoration in fluorescence intensity (Figure 15 (A)),
which is very high and inconsistent with previous data.32 Thus, we reduced the
concentration of GO used for the assay to 50 µg/mL to differentiate signals from varying
DNA concentrations (Figure 15 (B)). However, there was only a slight increase in
fluorescence intensity for 250 nM and 2.5 µM of target DNA.
(A)

(B)

Figure 15. Sensitivity determination using ZFP assay using 70 µg/mL of GO (A) and 50
µg/mL of GO (B) with increasing concentration of target DNA from 0 to 2.5 µM.
Since excess GO is unfavorable for desorption of ZFPs from GO surface, we
believed that using the minimal amount of GO for the assay would differentiate signals
from varying DNA concentrations. Further analysis of the quenching efficiency was
performed to determine the optimal GO concentration for ZFP assay (Figure 16). At 10
µg/mL of GO, the quenching efficiency was calculated to be 39%, consistent with previous
report of 42% for the same concentration of GO. (Figure 14 (C)). At 2 µg/mL of GO, the
quenching efficiency was calculated to be 3%. When the GO concentration was less than
2 µg/mL, there was hardly any quenching effect of QD-labeled ZFPs, which could be due
to the incomplete adsorption of ZFPs on GO surface. Thus, 2 µg/mL of GO was used
throughout the study.
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(A)

(B)

Figure 16. (A) Changes in fluorescence spectra by increasing GO concentrations from 0 to
10 µg/mL (B) The fluorescence quenching efficiency of QD-labeled ZFPs by increasing
concentrations of GO.
2.4 Sensitivity
ZFP assay was performed at various concentrations of target DNA ranging from
2.5 µM to 1 nM to determine the sensitivity of our system. Our sensitivity data (Figure 17)
was consistent with the previous report for this particular ZFP stx2_268.32 The percent
recovery of fluorescence signal was calculated using the following equation, where F0 and
F1 were the fluorescence intensity at the maxima in the absence and presence of GO, and
Fi was the fluorescence intensity at the maxima in the presence of target DNA:
% Fluorescence recovery = 100 −

𝐹0 − 𝐹𝑖
× 100
𝐹0 − 𝐹1

At 1 nM of target DNA, a fluorescence intensity recovery of 18% was observed.
Though we have not tried a lower concentration of target DNA, we believe that a lower
limit of detection could be potentially achieved. The fluorescence recovery was also
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linearly increased with increasing DNA concentrations. The limit of detection for ZFP
stx2_268 was determined to be 1 nM, which is equal to 200 fmol of target oligonucleotides.

Figure 17. The limit of detection of the ZFP stx2_268 at 10 nM.
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CHAPTER IV – CONCLUSION
In the first part of our study, we have demonstrated the direct detection of the
pathogen-specific dsDNA sequence utilizing engineered ZFPs arrayed on the copolymer
chip. Our system avoids multiple laborious steps involved in DNA denaturation and
subsequent hybridization, and DNA-labeling, providing a key to a simple and rapid DNA
sensing technology. Our ZFP pairs showed high specificity and sensitivity toward their
own target DNAs, suggesting that ZFP arrays on the COC chip could be further developed
into a novel and reliable molecular device for pathogen detection. Our future study will
focus on exploring immobilization methods for ZFPs and methods of signal amplification
to achieve improved sensitivity. In the near future, we envision a lab-on-a-chip diagnostic
by integrating our system with a microfluidic module. If more complex biological samples
such as bacterial cell lysates are used on the microfluidic module integrated system, it
would allow for the pre-concentration of cell lysates.70 Thus, it could enable us to lower
the current limit of detection. In our previous study,16 our assay system was still able to
detect the target DNA in the presence of complex genomic DNA that would act as a
competitor for specific binding. It was noted that ZFPs are stable at room temperature while
the assay is being performed for many hours. Also, we would expect that ZFPs are fairly
tolerant to the biological samples such as cell lysates, and thus ZFP performance would not
be affected by the cell lysate sample. Taken together, the stability and performance of ZFPs
would not be a significant concern when using biological samples. In summary, our
approach has demonstrated three different sets of ZFPs that specifically bind to three
different target DNA sequences within the stx2 gene. For multiplexed detection, multiple
ZFPs that recognize different target DNAs can be engineered and arrayed on the surface.
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The use of ZFPs makes our system novel because it does not require DNA denaturation
and subsequent hybridization unlike the leading DNA-based methods. Our system
generating a visual color change is suitable for POC diagnostics since it does not require
labeling or sophisticated instrumentation in addition to the thermoplastic polymer COC
surface as an ideal lab-on-a- chip platform. While ZFPs provide a powerful scaffold for
custom-designed DNA-binding proteins, a new class of DNA-binding domains, TALEs
(transcriptional activator-like effectors), could be engineered for a new diagnostic probe
for detecting multiple pathogens. Compared to ZFPs, TALEs exhibit more modular
architecture and flexibility for design, which could make TALE performance favorable for
diagnostic applications.
In the second part of our study, we have developed a new GO-based sensing
technology for the direct detection of the pathogen-specific dsDNA sequence utilizing
engineered ZFP. Similar to the first part of our study, this GO-based method is also novel
because it does not require DNA denaturation and subsequent hybridization. Our GO-based
sensor with ZFPs provided a detection limit of 1 nM. Even though the sensitivity for this
system is twenty-fold less than that of the ZFP array, we believe that the sensitivity of this
system could be further improved. We would expect that reducing the total assay volume
and increasing the amount of labeled ZFPs in the assay could enable us to lower the current
limit of detection. In our future study, we will further optimize our assay conditions to
improve the sensitivity in order to be competitive with other leading DNA techniques.
Furthermore, with the advantages of QDs, this system enables multiplexing by labeling
different ZFPs with various QDs of different emission peaks. Most importantly, with a total
assay time of approximately 20 minutes, this system is even faster than our ZFP array,
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which has total arraying time of approximately one and a half hour. In summary, our
approach has demonstrated for the first time that engineered ZFPs can be adsorbed on GO
surface for direct detection of dsDNA. In near future, we expect to to apply multiplexing
to this system to develop a new screening technology for multiple antibiotic resistance
genes.
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